Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pulmonary Fibrosis Clinical Trials Analysis Overview
The Pulmonary Fibrosis clinical trial report consists of 859 trials. The report provides an overview of the Pulmonary Fibrosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Pulmonary Fibrosis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report includes the names of prominent sponsors involved with conducting the Pulmonary Fibrosis clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · The UK · Japan · Australia · Germany |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · C. H. Boehringer Sohn AG & Co KG
· F. Hoffmann-La Roche Ltd · Bristol-Myers Squibb Co · Galapagos NV · Johnson & Johnson · Laboratory Corp of America Holdings · Others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Pulmonary Fibrosis Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Pulmonary Fibrosis clinical trials landscape with more than 35% of the clinical trials conducted there as of October 2023.
The key regions considered for Pulmonary Fibrosis clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In a country-wise analysis, as of October 2023, the US accounted for the highest number of Pulmonary Fibrosis clinical trials, followed by China and the UK.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, Italy has the highest proportion of Pulmonary Fibrosis to Respiratory clinical trials as of October 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, Mexico has the highest proportion of Pulmonary Fibrosis to Respiratory clinical trials as of October 2023.
Pulmonary Fibrosis Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Pulmonary Fibrosis Clinical Trials
Pulmonary Fibrosis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Pulmonary Fibrosis clinical trials are company, institution, and the government. As of October 2023, the company sponsor type dominated the Pulmonary Fibrosis clinical trials share, followed by institution.
Pulmonary Fibrosis Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Pulmonary Fibrosis Clinical Trials
Pulmonary Fibrosis Clinical Trials - Competitive Landscape
In 2023, C. H. Boehringer Sohn AG & Co KG and F. Hoffmann-La Roche Ltd have conducted the highest number of pulmonary fibrosis clinical trials.
Some of the leading sponsors for Pulmonary Fibrosis clinical trials are:
- H. Boehringer Sohn AG & Co KG
- Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Co
- Galapagos NV
- Johnson & Johnson
- Laboratory Corp of America Holdings
Pulmonary Fibrosis Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More About the Leading Players of Pulmonary Fibrosis Clinical Trials
Segments Covered in the Report
Pulmonary Fibrosis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Pulmonary Fibrosis Clinical Trials Country Outlook (2023)
- The US
- China
- The UK
- Japan
- Australia
- Germany
Pulmonary Fibrosis Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Co
Galapagos NV
Johnson & Johnson
Laboratory Corp of America Holdings
ICON Plc
Vicore Pharma Holding AB
Sanofi
Crescent Capital Partners
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Pulmonary Fibrosis clinical trials?
Asia-Pacific accounted for the highest number of Pulmonary Fibrosis clinical trials as of October 2023.
-
Which country conducted the highest number of Pulmonary Fibrosis clinical trials?
The US conducted the highest number of Pulmonary Fibrosis clinical trials as of October 2023.
-
Which sponsor type was the most prominent in the Pulmonary Fibrosis clinical trials?
Company was the most prominent sponsor type for Pulmonary Fibrosis clinical trials.
-
Who are the leading sponsors of Pulmonary Fibrosis clinical trials?
Some of the leading sponsors of Pulmonary Fibrosis clinical trials are C. H. Boehringer Sohn AG & Co KG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Co, Galapagos NV, Johnson & Johnson, and Laboratory Corp of America Holdings, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.